secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-PATH HOLDINGS, INC. (BPTH)
CIK:        0001133818
Form:       8-K
Filed at:   2022-12-20T23:59:59+00:00
Accession:  0001104659-22-128653
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Path stockholders approve 2022 Stock Incentive Plan, elect five directors
-----------------------------------------------------------------------------

- Approved 2022 Stock Incentive Plan authorizing up to 1,300,000 shares for equity awards.
- Re-elected directors: Peter H. Nielsen, Heath W. Cleaver, Paul D. Aubert, Aline Sherwood, Douglas P. Morris.
- Advisory vote on executive compensation approved (2,076,879 for, 237,410 against).
- Ratified Ernst & Young as independent auditor for fiscal 2022 (3,920,967 for, 300,923 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133818/000110465922128653/0001104659-22-128653-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133818/000110465922128653/tm2233060d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-128653

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer